Enzo Biochem, Inc. Common Stock ($0.01 Par Value) (ENZ)
0.6059
+0.0061 (1.02%)
Enzo Biochem is a biotechnology company focused on developing and commercializing innovative technologies for the healthcare and life sciences sectors
The company specializes in molecular diagnostics, offering a range of products and services designed to enhance the detection and monitoring of various diseases. In addition to diagnostic solutions, Enzo is involved in the research and development of therapeutic options, utilizing its expertise in biochemistry and molecular biology. Through its commitment to scientific advancement, Enzo Biochem aims to improve patient outcomes and support healthcare providers with valuable insights and tools.
Shares of PriceSmart, Inc. (NASDAQPSMT) rose sharply in today’s pre-market trading as the company posted better-than-expected earnings for its second quarter.
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 300 points on Friday. The Dow traded down 1.07% to 31,899.93 while the NASDAQ fell 0.68% to 11,638.13. The S&P 500, also fell, dropping, 0.94% to 3,923.10.
Gainers Enzo Biochem, Inc. (NYSEENZ) shares rose 89.9% to $2.26 in pre-market trading after the company announced it will sell its clinical laboratory to Labcorp.
Enzo Biochem Inc (NYSEENZ) shares are soaring in extended trading Thursday after the company agreed to sell its clinical lab to Laboratory Corporation Of America
The Dow Jones closed lower for the third straight session on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
